C0005516||marker
C2707001||human epididymis protein 4
C2603343||study
C0678222||Breast cancer
C0011900||diagnosed
C0006826||cancer
C0043210||women
C0041365||Tumor markers
C0521982||treatment response
C0596473||early diagnosis
C2707001||Human epididymis protein 4
C2707001||Human epididymis protein 4
C1171362||expressed
C1527349||ductal carcinoma of the breast tissue
C0229671||serum
C0011900||diagnostic
C0420834||prognostic
C0678222||breast cancer
C2603343||study
C0229671||serum
C2707001||Human epididymis protein 4
C1148554||determined
C0678222||breast cancer
C0029925||ovarian cancer
C1708335||healthy volunteers
C0678222||breast cancer
C0229671||serum
C2707001||Human epididymis protein 4
C0229671||serum
C2707001||Human epididymis protein 4
C0678222||breast cancer
C0029925||ovarian cancer
C1708335||healthy volunteers
C0678222||breast cancer
C1148554||determined
C2707001||Human epididymis protein 4
C1446409||positive
C0229671||serum
C2707001||Human epididymis protein 4
C0003341||cancer antigen
C1148554||determined
C0376554||knowledge
C2603343||study
C1148554||determine
C0229671||serum
C2707001||Human epididymis protein 4
C0678222||breast cancer
C0702240||elevation
C0229671||serum
C2707001||Human epididymis protein 4
C0678222||breast cancer
C2707001||Human epididymis protein 4
C0005516||biomarker
C0011900||diagnosis
C0678222||breast cancer